Search results
Novavax (NVAX) to Report Q4 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 1 year agoWe expect investors to focus on the sales performance of Novavax, Inc.’s NVAX protein-based COVID-19...
Novavax's (NVAX) COVID Jab Gets Full Approval in Europe
Zacks via Yahoo Finance· 10 months agoNovavax NVAX announced that the European Commission had granted full marketing authorization for its...
Novavax (NVAX) Q3 Earnings Miss, Lowers '22 Sales Outlook
Zacks via Yahoo Finance· 2 years agoNovavax, Inc. NVAX incurred a loss of $2.15 per share for third-quarter 2022, which missed the Zacks...
Novavax's COVID-19 Vaccine Gets Back To Back Approval In Japan, Australia For Adolescents
Benzinga via Yahoo Finance· 2 years agoNovavax Inc's (NASDAQ: NVAX) Nuvaxovid (NVX-CoV2373) COVID-19 vaccine received expanded...
Novavax (NVAX) COVID Jab Aids Growth, Overdependence a Challenge (revised)
Zacks via Yahoo Finance· 1 year agoThough Novavax, Inc. NVAX is one of a handful of vaccine makers that has secured authorizations for...
Novavax (NVAX) Gets Nod for COVID-19 Booster Jab in South Korea
Zacks via Yahoo Finance· 1 year agoNovavax NVAX announced that its partner SK bioscience received expanded manufacturing and marketing...
Novavax Covid Vaccine Could Soon Win EUA Approval — And So What?
TipRanks via Yahoo Finance· 2 years agoAt long last, Novavax (NVAX) may be close to getting its EUA. As the company announced late Tuesday,...
Novavax (NVAX) Q4 Earnings & Revenues Miss Estimates, Stock Down
Zacks via Yahoo Finance· 1 year agoNovavax (NVAX) reports worse-than-expected financial performance in the fourth quarter of 2022, with...
Novavax Says Initial 1M Doses Of Nuvaxovid COVID-19 Vaccine Are Available In UK
Benzinga via Yahoo Finance· 2 years agoNovavax Inc (NASDAQ: NVAX) announced that an initial one million doses of Nuvaxovid (NVX-CoV2373)...
Novavax' Sees Conditional Approval Of COVID-19 Vaccine Booster In Australia As US FDA Delays Its...
Benzinga via Yahoo Finance· 2 years agoThe Australian regulatory authority has conditionally approved Novavax Inc's (NASDAQ: NVAX)...